Olpha Competitors and Similar CompaniesClear all
Merus's competitors and similar companies include Aerie Pharmaceuticals.
 Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 2003 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 260 | Employees 3808% increase |
Valuation ($) | Valuation ($) 3.6 b | Valuation ($) 722.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $26.8m (FY, 2021) |
Net income | Net income ($215.3m) (FY, 2024) | Net income ($74.8m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 149.3m | Total funding raised $ 388.6m |
For sources of this data, please see the company profile
View Company Profiles
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company